Search

Your search keyword '"Moros, María"' showing total 340 results

Search Constraints

Start Over You searched for: Author "Moros, María" Remove constraint Author: "Moros, María"
340 results on '"Moros, María"'

Search Results

301. Reversible Alignment of Nanoparticles and Intracellular Vesicles During Magnetic Hyperthermia Experiments.

302. Methodology and Application of Statistical Techniques to Evaluate the Reliability of Electrical Systems Based on the Use of High Variability Generation Sources.

303. Monosaccharides versusPEG-Functionalized NPs: Influence in the Cellular Uptake

304. Comparative severity of COVID-19 cases caused by Alpha, Delta or Omicron SARS-CoV-2 variants and its association with vaccination

305. Chronic diseases as a priority for the public health surveillance system in Spain

306. Remote Magneto–Thermal Modulation of Reactive Oxygen Species Balance Enhances Tissue Regeneration In Vivo.

307. Nanoparticles engineered to bind cellular motors for efficient delivery.

308. Postabortal haemorrhage and disseminated intravascular coagulation due to placenta accreta.

309. Tailoring the Magnetic and Structural Properties of Manganese/Zinc Doped Iron Oxide Nanoparticles through Microwaves-Assisted Polyol Synthesis.

310. Risk mapping of West Nile virus circulation in Spain, 2015.

311. Estudio del comportamiento de una membrana de nanofiltración de bajo ensuciamiento frente a disoluciones iónicas. Desarrollo de metodologías de ajuste de los parámetros del modelo DSPM con efectos dieléctricos

312. Interactions of magnetic nanoparticles with proteins, cells and living organisms for magnetic hyperthermia applications

313. Characterization of the first autochthonous dengue outbreak in Spain (August–September 2018).

314. DNA as a tool for drug design and magnetic hyperthermia analysis

315. Design of a Magnetic Nanoplatform Based on CD26 Targeting and HSP90 Inhibition for Apoptosis and Ferroptosis-Mediated Elimination of Senescent Cells.

316. Membrane-localized magnetic hyperthermia promotes intracellular delivery of cell-impermeant probes.

317. Marked increase in cryptosporidiosis cases, Spain, 2023.

318. Comparative severity of COVID-19 cases caused by Alpha, Delta or Omicron SARS-CoV-2 variants and its association with vaccination.

319. A Simple and Versatile Strategy for Oriented Immobilization of His-Tagged Proteins on Magnetic Nanoparticles.

320. Influenza A(H5N1) detection in two asymptomatic poultry farm workers in Spain, September to October 2022: suspected environmental contamination.

321. Lifting COVID-19 mitigation measures in Spain (May-June 2020).

322. Mpox (formerly monkeypox) in women: epidemiological features and clinical characteristics of mpox cases in Spain, April to November 2022.

323. [Long-term care facilities (LTCF) for the elderly: the surveillance of communicable diseases as part of health care and protection.]

324. Epidemiologic Features and Control Measures during Monkeypox Outbreak, Spain, June 2022.

325. Iron Speciation in Animal Tissues Using AC Magnetic Susceptibility Measurements: Quantification of Magnetic Nanoparticles, Ferritin, and Other Iron-Containing Species.

326. [The impact of COVID-19 on sick leave of the persons working in nursing homes in Spain. Usefulness of sick leave for the surveillance of the pandemic evolution.]

327. Magnetogenetics: remote activation of cellular functions triggered by magnetic switches.

328. [Lessons learnt from COVID-19 surveillance. Urgent need for a new public health surveillance. SESPAS Report 2022].

329. Lifting COVID-19 mitigation measures in Spain (May-June 2020).

330. Unprecedented increase of West Nile virus neuroinvasive disease, Spain, summer 2020.

331. [Zika virus epidemic. The Public Health response in Spain].

332. Double-balloon catheter for induction of labour in women with a previous cesarean section, could it be the best choice?

334. [Chronic diseases as a priority for the public health surveillance system in Spain].

335. [Possible introduction and autochthonous transmission of dengue virus in Spain].

336. [Comparative study between pregnancies induced for premature rupture of membranes and for prolonged pregnancy].

337. Tips for the functionalization of nanoparticles with antibodies.

338. [Review of the current situation and the risk factors of Leishmania infantum in Spain].

339. Taking advantage of unspecific interactions to produce highly active magnetic nanoparticle-antibody conjugates.

340. [Monitoring and non pharmacologic measures during a pandemic virus (H1N1) 2009 in Spain].

Catalog

Books, media, physical & digital resources